Yueh-Bih Tang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yueh-Bih Tang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Bien-Keem Tan
3 shared publications- Hung-Chi Chen
Department of Plastic and Reconstructive Surgery China Medical University Hospital Taichung Taiwan
3 shared publications - Nai-Chen Cheng
Department of Surgery, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan
3 shared publications Atakan Aydin
Taipei, Taiwan
2 shared publicationsHasu Patel
Taipei, Taiwan
2 shared publications- Hung-Chih Chen
Department of Ophthalmology, Show Chwan Memorial Hospital, Changhua 500, Taiwan
2 shared publications
Latest Publications
- 28 January 2008
- Published by Wiley in Head & Neck
- Vol. 30 (7) , 829-835
Microvascular head and neck reconstruction in patients with liver cirrhosis
- 28 January 2008
- Published by Wiley in Head & Neck
- Vol. 30 (7) , 829-835
Microvascular head and neck reconstruction in patients with liver cirrhosis
- 17 March 2007
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 38 (3) , 177-182
Fiber type and myosin heavy chain compositions of adult pretarsal orbicularis oculi muscle
Pretarsal orbicularis oculi muscle (POOM) is an important structure of eyelid movement in human. The aim of this study was to investigate fiber histomorphology and myosin heavy chain (MyHC) isoform composition of adult POOM, and to clarify their age-related changes. Eyelid specimens from 58 subjects (age range, 21 to 91 years) were collected during upper blepharoplasty procedures. Serial cross sections of POOM were ATPase-stained and examined under miscroscope. Quantitative measures of muscle fiber size and fiber type distribution were obtained in 35 subjects with adequate fiber cross sections. Relative MyHC isoform contents of POOM were retrieved by gel electrophoresis in all 58 subjects. Examination of the histochemical staining revealed an abundance of type II fiber ( >85%) in human POOM, with more type IIX than IIA fibers. Decreased mean area of all fibers and type IIA fibers were noted in the old group when compared to the young. As for MyHC analysis, the relative content of MyHC isoforms exhibited an order of IIX > IIA > I, and the relative MyHC IIA content showed a negative correlation with age. Comparing with previous studies of limb or masticatory muscles, adult POOM exhibits a unique fiber and MyHC composition, as well as a different aging pattern.
- 17 March 2007
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 38 (3) , 177-182
Fiber type and myosin heavy chain compositions of adult pretarsal orbicularis oculi muscle
Pretarsal orbicularis oculi muscle (POOM) is an important structure of eyelid movement in human. The aim of this study was to investigate fiber histomorphology and myosin heavy chain (MyHC) isoform composition of adult POOM, and to clarify their age-related changes. Eyelid specimens from 58 subjects (age range, 21 to 91 years) were collected during upper blepharoplasty procedures. Serial cross sections of POOM were ATPase-stained and examined under miscroscope. Quantitative measures of muscle fiber size and fiber type distribution were obtained in 35 subjects with adequate fiber cross sections. Relative MyHC isoform contents of POOM were retrieved by gel electrophoresis in all 58 subjects. Examination of the histochemical staining revealed an abundance of type II fiber ( >85%) in human POOM, with more type IIX than IIA fibers. Decreased mean area of all fibers and type IIA fibers were noted in the old group when compared to the young. As for MyHC analysis, the relative content of MyHC isoforms exhibited an order of IIX > IIA > I, and the relative MyHC IIA content showed a negative correlation with age. Comparing with previous studies of limb or masticatory muscles, adult POOM exhibits a unique fiber and MyHC composition, as well as a different aging pattern.
- Open Access
- 2 March 2007
- Published by Springer Nature in Cancer Cell International
- Vol. 7 (1) , 1-10
Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis
Background: Prolactinoma is the most frequent pituitary tumor in humans. The dopamine D2 receptor agonist bromocriptine has been widely used clinically to treat human breast tumor and prolactinoma through inhibition of hyperprolactinemia and induction of tumor cell apoptosis, respectively, but the molecular mechanism of bromocriptine induction of pituitary tumor apoptosis remains unclear. Caveolin-1 is a membrane-anchored protein enriched on caveolae, inverted flask-shaped invaginations on plasma membranes where signal transduction molecules are concentrated. Currently, caveolin-1 is thought to be a negative regulator of cellular proliferation and an enhancer of apoptosis by blocking signal transduction between cell surface membrane receptors and intracellular signaling protein cascades. Rat pituitary adenoma GH3 cells, which express endogenous caveolin-1, exhibit increased apoptosis and shrinkage after exposure to bromocriptine. Hence, the GH3 cell line is an ideal model for studying the molecular action of bromocriptine on prolactinoma. Results: The expression of endogenous caveolin-1 in GH3 cells was elevated after bromocriptine treatment. Transiently expressed mouse recombinant caveolin-1 induced apoptosis in GH3 cells by enhancing the activity of caspase 8. Significantly, caveolin-1 induction of GH3 cell apoptosis was sensitized by the administration of bromocriptine. Phosphorylation of caveolin-1 at tyrosine 14 was enhanced after bromocriptine treatment, suggesting that bromocriptine-induced phosphorylation of caveolin-1 may contribute to sensitization of apoptosis in GH3 cells exposed to bromocriptine. Conclusion: Our results reveal that caveolin-1 increases sensitivity for apoptosis induction in pituitary adenoma GH3 cells and may contribute to tumor shrinkage after clinical bromocriptine treatment.
- 2 March 2007
- Published by Springer Nature in Cancer Cell International
- Vol. 7 (1) , 1-10
Open AccessCaveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis
Background: Prolactinoma is the most frequent pituitary tumor in humans. The dopamine D2 receptor agonist bromocriptine has been widely used clinically to treat human breast tumor and prolactinoma through inhibition of hyperprolactinemia and induction of tumor cell apoptosis, respectively, but the molecular mechanism of bromocriptine induction of pituitary tumor apoptosis remains unclear. Caveolin-1 is a membrane-anchored protein enriched on caveolae, inverted flask-shaped invaginations on plasma membranes where signal transduction molecules are concentrated. Currently, caveolin-1 is thought to be a negative regulator of cellular proliferation and an enhancer of apoptosis by blocking signal transduction between cell surface membrane receptors and intracellular signaling protein cascades. Rat pituitary adenoma GH3 cells, which express endogenous caveolin-1, exhibit increased apoptosis and shrinkage after exposure to bromocriptine. Hence, the GH3 cell line is an ideal model for studying the molecular action of bromocriptine on prolactinoma. Results: The expression of endogenous caveolin-1 in GH3 cells was elevated after bromocriptine treatment. Transiently expressed mouse recombinant caveolin-1 induced apoptosis in GH3 cells by enhancing the activity of caspase 8. Significantly, caveolin-1 induction of GH3 cell apoptosis was sensitized by the administration of bromocriptine. Phosphorylation of caveolin-1 at tyrosine 14 was enhanced after bromocriptine treatment, suggesting that bromocriptine-induced phosphorylation of caveolin-1 may contribute to sensitization of apoptosis in GH3 cells exposed to bromocriptine. Conclusion: Our results reveal that caveolin-1 increases sensitivity for apoptosis induction in pituitary adenoma GH3 cells and may contribute to tumor shrinkage after clinical bromocriptine treatment.
- 1 May 2006
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 88 (5) , 1107-1110
NECROTIZING FASCIITIS CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS RESULTING IN DEATH
- 1 May 2006
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 88 (5) , 1107-1110
NECROTIZING FASCIITIS CAUSED BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS RESULTING IN DEATH
- 1 May 2006
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 88 (5) , 1107-1110
Necrotizing Fasciitis Caused by Methicillin-Resistant Staphylococcus aureus Resulting in Death
- 1 May 2006
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 88 (5) , 1107-1110
Necrotizing Fasciitis Caused by Methicillin-Resistant Staphylococcus aureus Resulting in Death
- 1 January 2004
- Published by Wiley in Microsurgery
- Vol. 24 (4) , 270-280
Reconstruction of the hand and upper limb with free flaps based on musculocutaneous perforators
Since the advent of perforator flaps, a wide variety of applications have been documented. This study focuses on free flaps based on musculocutaneous perforators, because they have not been well‐described in the literature of upper‐limb reconstruction. They can be trimmed to be thin and pliable, and may provide large flaps with multiple components on the same pedicle to facilitate three‐dimensional inset of flaps. Microvascular free flaps based on musculocutaneous perforators were performed in 36 cases for reconstruction of the thumb and thenar web, palm, dorsum of the hand, wrist, and forearm. They included the anterolateral thigh perforator flap (27 cases), thoracodorsal perforator flap (5 cases), and deep inferior epigastric perforator flap (4 cases). In 2 other cases not included in this series, the thoracodorsal perforator flap could not be elevated due to anatomical variations. There was no failure in this series, but complications included: 1) hematoma in 2 cases, and 2) infection in 2 cases with flap rim necrosis which was treated by a local rotation flap and skin graft. The thin flaps facilitated secondary reconstructive procedures, and only minor effort was required for the debulking procedure of the flaps. On average, these patients required 2.3 occasions of secondary procedures for further reconstruction following coverage with a perforator flap. The perforator flaps provide medium‐thickness flaps for coverage of large defects in the upper limb with improved aesthetics and function. With careful dissection of the musculocutaneous perforators and primary thinning of the flaps, the use of a perforator flap is quite safe. Preservation of the muscles leads to better preservation of donor‐site functions. Less requirement of secondary debulking procedures is a great advantage. However, caution should be taken in the presence of wound infection.
- 1 January 2004
- Published by Wiley in Microsurgery
- Vol. 24 (4) , 270-280
Reconstruction of the hand and upper limb with free flaps based on musculocutaneous perforators
Since the advent of perforator flaps, a wide variety of applications have been documented. This study focuses on free flaps based on musculocutaneous perforators, because they have not been well‐described in the literature of upper‐limb reconstruction. They can be trimmed to be thin and pliable, and may provide large flaps with multiple components on the same pedicle to facilitate three‐dimensional inset of flaps. Microvascular free flaps based on musculocutaneous perforators were performed in 36 cases for reconstruction of the thumb and thenar web, palm, dorsum of the hand, wrist, and forearm. They included the anterolateral thigh perforator flap (27 cases), thoracodorsal perforator flap (5 cases), and deep inferior epigastric perforator flap (4 cases). In 2 other cases not included in this series, the thoracodorsal perforator flap could not be elevated due to anatomical variations. There was no failure in this series, but complications included: 1) hematoma in 2 cases, and 2) infection in 2 cases with flap rim necrosis which was treated by a local rotation flap and skin graft. The thin flaps facilitated secondary reconstructive procedures, and only minor effort was required for the debulking procedure of the flaps. On average, these patients required 2.3 occasions of secondary procedures for further reconstruction following coverage with a perforator flap. The perforator flaps provide medium‐thickness flaps for coverage of large defects in the upper limb with improved aesthetics and function. With careful dissection of the musculocutaneous perforators and primary thinning of the flaps, the use of a perforator flap is quite safe. Preservation of the muscles leads to better preservation of donor‐site functions. Less requirement of secondary debulking procedures is a great advantage. However, caution should be taken in the presence of wound infection.
- 1 July 2003
- Published by Elsevier in Clinics in Plastic Surgery
- Vol. 30 (3) , 383-401
Anterolateral thigh flap: an ideal soft tissue flap
- 1 July 2003
- Published by Elsevier in Clinics in Plastic Surgery
- Vol. 30 (3) , 383-401
Anterolateral thigh flap: an ideal soft tissue flap
- 1 January 2003
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 111 (1) , 336-340
Talking Jejunum: A New, Safe Technique for Voice Reconstruction Using Free-Jejunum Transfer
- 1 January 2003
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 111 (1) , 336-340
Talking Jejunum: A New, Safe Technique for Voice Reconstruction Using Free-Jejunum Transfer
- 1 January 2003
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 111 (1) , 336-340
Talking Jejunum: A New, Safe Technique for Voice Reconstruction Using Free-Jejunum Transfer
An abstract is unavailable. This article is available as a PDF only.
- 1 January 2003
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 111 (1) , 336-340
Talking Jejunum: A New, Safe Technique for Voice Reconstruction Using Free-Jejunum Transfer
An abstract is unavailable. This article is available as a PDF only.
- 1 March 2002
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 73 (3) , 987-989
Behavior of free jejunal flaps after early disruption of blood supply
- 1 March 2002
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 73 (3) , 987-989
Behavior of free jejunal flaps after early disruption of blood supply